259 related articles for article (PubMed ID: 14581338)
1. Studies of apurinic/apyrimidinic endonuclease/ref-1 expression in epithelial ovarian cancer: correlations with tumor progression and platinum resistance.
Freitas S; Moore DH; Michael H; Kelley MR
Clin Cancer Res; 2003 Oct; 9(13):4689-94. PubMed ID: 14581338
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers.
Moore DH; Michael H; Tritt R; Parsons SH; Kelley MR
Clin Cancer Res; 2000 Feb; 6(2):602-9. PubMed ID: 10690545
[TBL] [Abstract][Full Text] [Related]
3. Nuclear expression of apurinic/apyrimidinic endonuclease increases with progression of ovarian carcinomas.
Tanner B; Grimme S; Schiffer I; Heimerdinger C; Schmidt M; Dutkowski P; Neubert S; Oesch F; Franzen A; Kölbl H; Fritz G; Kaina B; Hengstler JG
Gynecol Oncol; 2004 Feb; 92(2):568-77. PubMed ID: 14766249
[TBL] [Abstract][Full Text] [Related]
4. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
Zhang Y; Wang J; Xiang D; Wang D; Xin X
Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
[TBL] [Abstract][Full Text] [Related]
5. Differential cellular and subcellular expression of the human multifunctional apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme.
Duguid JR; Eble JN; Wilson TM; Kelley MR
Cancer Res; 1995 Dec; 55(24):6097-102. PubMed ID: 8521399
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation.
Robertson KA; Bullock HA; Xu Y; Tritt R; Zimmerman E; Ulbright TM; Foster RS; Einhorn LH; Kelley MR
Cancer Res; 2001 Mar; 61(5):2220-5. PubMed ID: 11280790
[TBL] [Abstract][Full Text] [Related]
7. The apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme is elevated in premalignant and malignant cervical cancer.
Xu Y; Moore DH; Broshears J; Liu L; Wilson TM; Kelley MR
Anticancer Res; 1997; 17(5B):3713-19. PubMed ID: 9427767
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of human apurinic/apyrimidinic endonuclease (APE/Ref-1) expression in rectal cancer treated with preoperative radiochemotherapy.
Kim JS; Kim JM; Liang ZL; Jang JY; Kim S; Huh GJ; Kim KH; Cho MJ
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):130-7. PubMed ID: 21075552
[TBL] [Abstract][Full Text] [Related]
9. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer.
Kelley MR; Cheng L; Foster R; Tritt R; Jiang J; Broshears J; Koch M
Clin Cancer Res; 2001 Apr; 7(4):824-30. PubMed ID: 11309329
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of APE/ref-1 in recurrence stage I, non small cell lung cancer.
Kang MW; Kang SK; Choi S; Lee CS; Jeon BH; Lim SP
Asian Cardiovasc Thorac Ann; 2012 Feb; 20(1):36-41. PubMed ID: 22371940
[TBL] [Abstract][Full Text] [Related]
11. The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis.
Zou GM; Karikari C; Kabe Y; Handa H; Anders RA; Maitra A
J Cell Physiol; 2009 Apr; 219(1):209-18. PubMed ID: 19097035
[TBL] [Abstract][Full Text] [Related]
12. Oxidative cellular damage and the reduction of APE/Ref-1 expression after experimental traumatic brain injury.
Lewén A; Sugawara T; Gasche Y; Fujimura M; Chan PH
Neurobiol Dis; 2001 Jun; 8(3):380-90. PubMed ID: 11447995
[TBL] [Abstract][Full Text] [Related]
13. Early decrease of apurinic/apyrimidinic endonuclease expression after transient focal cerebral ischemia in mice.
Fujimura M; Morita-Fujimura Y; Kawase M; Chan PH
J Cereb Blood Flow Metab; 1999 May; 19(5):495-501. PubMed ID: 10326716
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of Ape/Ref-1 subcellular expression in stage I-III breast carcinomas.
Puglisi F; Barbone F; Tell G; Aprile G; Pertoldi B; Raiti C; Kelley MR; Damante G; Sobrero A; Beltrami CA; Di Loreto C
Oncol Rep; 2002; 9(1):11-7. PubMed ID: 11748448
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of the DNA repair protein APE/REF-1 by CKII affects redox regulation of AP-1.
Fritz G; Kaina B
Oncogene; 1999 Jan; 18(4):1033-40. PubMed ID: 10023679
[TBL] [Abstract][Full Text] [Related]
16. Decisive role of apurinic/apyrimidinic endonuclease/Ref-1 in initiation of cell death.
Cho KJ; Kim HJ; Park SC; Kim HW; Kim GW
Mol Cell Neurosci; 2010 Nov; 45(3):267-76. PubMed ID: 20637286
[TBL] [Abstract][Full Text] [Related]
17. Altered level of apurinic/apyrimidinic endonuclease/redox factor-1 (APE/REF-1) mRNA in the hippocampus of ovariectomized rats treated by raloxifene against kainic acid.
Yalcin A; Kanit L; Durmaz G; Sargin S; Terek CH; Tanyolac B
Clin Exp Pharmacol Physiol; 2005 Aug; 32(8):611-4. PubMed ID: 16120186
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of apurinic/apyrimidinic endonuclease expression is associated with the induction of apoptosis in differentiating myeloid leukemia cells.
Robertson KA; Hill DP; Xu Y; Liu L; Van Epps S; Hockenbery DM; Park JR; Wilson TM; Kelley MR
Cell Growth Differ; 1997 Apr; 8(4):443-9. PubMed ID: 9101090
[TBL] [Abstract][Full Text] [Related]
19. Redox effector factor-1, combined with reactive oxygen species, plays an important role in the transformation of JB6 cells.
Yang S; Misner BJ; Chiu RJ; Meyskens FL
Carcinogenesis; 2007 Nov; 28(11):2382-90. PubMed ID: 17566060
[TBL] [Abstract][Full Text] [Related]
20. Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic significance.
Wang L; Ma J; Liu F; Yu Q; Chu G; Perkins AC; Li Y
Gynecol Oncol; 2007 Jun; 105(3):695-702. PubMed ID: 17368732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
